Specimen Collection Card Market Report: Trends, Forecast and Competitive Analysis to 2030

Specimen Collection Card Trends and Forecast

The future of the global specimen collection card market looks promising with opportunities in the hospital & clinic and diagnostic center markets. The global specimen collection card market is expected to grow with a CAGR of 5.3% from 2024 to 2030. The major drivers for this market are rising emphasis on non-invasive procedures and growing cases of infectious diseases.

• Lucintel forecasts that, within the application category, new born screening will remain the largest segment over the forecast period.

• Within the end use category, hospital & clinic will remain a larger segment over the forecast period.

• In terms of regions, North America will remain the largest region over the forecast period. Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Specimen Collection Card Market

Emerging trends observed in this market sector are expected to bring about significant changes to its future applications and dynamics.

• Integration with Digital Health Systems: A growing number of specimen collection cards are becoming integrated with digital health platforms (Morris et al., 2015). This practice involves employing technologies that enable instantaneous or live transfer or upload of data, enhancing efficiency and accuracy when conducting diagnosis. Furthermore, it simplifies capturing information from patients’ EHRs, helping improve overall patient care outcomes since all essential elements are stored electronically.

• Enhanced Biocompatibility and Stability: Advances in materials science are resulting in the creation of new types of specimen collection cards that possess improved biocompatibility properties alongside other features like enhanced sample stability (Winkler, 2012). To ensure samples remain intact over long periods after being collected using them, novel coatings, adhesives, or polymers are necessary to preserve biomarkers without degrading the physicochemical characteristics vital for identification purposes later on in medical laboratories.

• Point-of-Care Testing: The use of specimen collection cards as a means of point-of-care (POC) testing has been increasing. This is due to a growing demand for diagnostic tools that are convenient and fast yet can be used outside the traditional laboratory environment. Innovations in card design and materials have made POC testing easier to reach and more reliable.

• Sustainability and Eco-Friendly Materials: In the market, there is a shift towards more sustainable and eco-friendly specimen collection cards. Manufacturers are exploring biodegradable or recyclable materials to improve environmental friendliness. Green solutions reflect global sustainability goals and address rising regulatory pressures as well as consumer preferences.

• Advanced Biomarker Detection Technologies: Developments in biomarker detection technologies are improving the capabilities of specimen collection cards. New advancements include better ways of detecting low levels of markers defined as biomarkers, increasing sensitivity and specificity in tests. These technologies allow for expanding disease spectra by using specimen collection cards. These emerging trends show how the specimen card collection market has dynamically grown due to technological change, a focus on sustainability, and the need for more efficient healthcare solutions.

Recent Developments in the Specimen Collection Card Market

Recent developments have underscored ongoing innovations and advances in the market for specimen collection cards.

• Digital Integration and Data Management: One of these significant advances includes linking electronic health systems with specimen collection cards. This involves utilizing barcodes or RFID tags that simplify information gathering and analysis processes. This will enable real-time monitoring of samples, ensuring that patient information is managed efficiently and improving accuracy and speed during the diagnostic process.

• Improved Stability through Advanced Materials: Recently, material science has resulted in the creation of sample test cards that are stable and compatible with living tissues. New material designs, such as special coatings or advanced polymers applied to these test plates, help maintain their integrity over time so accurate results can be obtained from an assay performed many years ago.

• Expansion of Applications: Apart from traditional uses, specimen collection cards are now being used in other areas. Developments in card design and materials have expanded their scope into different diagnostic realms such as newborn screening, infectious disease testing, and therapeutic drug monitoring. This expansion has been necessitated by the need for versatile and reliable diagnostic tools across various healthcare settings.

• Sustainability Focus: There is an increasing demand to develop green specimen collection cards. Biodegradable or recyclable alternatives are being explored by manufacturers to reduce environmental pollution. This movement aligns with global goals of sustainability while addressing regulatory pressures for more environmentally responsible products.

• Improved Quality Control and Manufacturing Processes: Advances in manufacturing technologies are leading to higher quality and consistency in specimen collection cards. Ensuring that the performance characteristics of cards meet exacting accuracy and reliability standards through enhanced quality control processes helps safeguard the validity of diagnostic tests and ensure patient safety. These developments demonstrate ongoing progress within the industry's commitment to innovation and quality, reflected in growth in digital integration, material advancements, and expanding applications, thus emphasizing the market progress being made towards further integrating digitalization in healthcare systems and developing advanced technologies that will facilitate new applications for diagnostic purposes.

Strategic Growth Opportunities for Specimen Collection Card Market

There are several strategic opportunities across the market, including:

• Expansion into Emerging Markets: Healthcare infrastructure has been growing rapidly in emerging markets, creating significant growth potential. This means that diagnostic tools that are affordable and accessible need to be made through the expansion of distribution and localizing manufacturing. The company can target regions where healthcare requirements are increasing to win new business and grow sales.

• Investment in Advanced Technologies: Advanced biomarker detection technologies and digital integration for specimen collection cards can help improve their functionality. Some of these may include real-time data transfer or sample stability enhancements, conferring them with a competitive edge over rivals. They should be developed according to the changing requirements of healthcare providers.

• Development of Eco-Friendly Products: Manufacturers can develop eco-friendly specimen collection cards because consumers increasingly demand sustainable products. This might involve using recyclable or biodegradable materials, appealing to environmentally conscious customers while adhering to global sustainability trends and regulatory requirements.

• Expansion into Point-of-Care Testing: Developing specimen collection cards for rapid and convenient diagnostics, due to the growing trend towards point-of-care testing, presents opportunities. Card features that support POC testing should be enhanced to create more market applications and efficient diagnostic solutions for various settings.

• Collaboration with Digital Health Platforms: The capabilities of specimen collection cards can be enhanced by collaborating with digital health technology providers. Linking electronic health records (EHRs) and digital diagnostic tools through card integration facilitates efficient data management throughout healthcare processes. These strategic growth opportunities highlight areas where companies can leverage innovation, market expansion, and sustainability efforts to drive growth and strengthen their competitive position in the specimen collection card market.

Specimen Collection Card Market Driver and Challenges

In the medical and diagnostic sector, the specimen collection card market is a key component that plays a major role in the effective and accurate collection, storage, and transportation of biological samples. Specimen collection cards are typically employed in newborn screening, genetic testing, infectious disease surveillance, and other diagnosis-related tasks. Their importance lies in aiding early disease detection, ensuring dependability of outcomes, and rationalizing the handling of samples. The factors responsible for driving the specimen collection card market include:

• Growing Demand for Diagnostic Testing: The increasing incidence of chronic diseases and infectious ailments is fueling a demand for reliable and effective diagnostic tools. Specimen collection cards are essential for various diagnostic applications, including newborn screening and infectious disease testing, thereby supporting market growth.

• Technological Advancements: Innovations in materials and technology, such as improved biomarker detection and digital integration, have enhanced the functionality of specimen collection cards. This has led to increased adoption by healthcare providers and an extension of their uses.

• Expansion of Healthcare Infrastructure: The expansion of healthcare infrastructure in emerging markets creates new opportunities for manufacturers of specimen collection cards. As access to quality healthcare improves, the demand for diagnostic tools, including specimen collection cards, will rise, leading to market expansion.

• Regulatory Support for Newborn Screening: Government policies that support early identification of genetic and metabolic disorders drive up demand for specimen collection cards used in these tests. This makes government policies on newborn screening one of the key drivers behind this market growth. Challenges in the specimen collection card market include:

• High Production Costs: Advanced materials and technologies can be costly, impacting the overall cost of producing specimen collection cards. The low-cost operating environment requires manufacturers to balance performance with affordability.

• Regulatory Compliance: Complying with stringent regulations regarding specimen collection cards can be complex and costly. Continuous investment in quality control and certification processes is necessary to meet diverse international and local regulations.

• Environmental Impact and Sustainability: Companies face challenges in addressing environmental impacts during the production and disposal of specimen collection cards. Compliance with regulations and meeting consumer demands for more eco-friendly alternatives require engaging in sustainable practices and the development of sound ecological materials.

• Market Competition: The specimen collection card market is competitive, with numerous players offering a range of products. Differentiation and maintaining a competitive advantage necessitate constant innovation and research investments. Addressing these drivers and challenges is crucial for companies to succeed in the specimen collection card market. To navigate through these dynamics and attain growth, there should be a focus on innovation, regulatory compliance, and sustainability efforts.

List of Specimen Collection Card Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies specimen collection card companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the specimen collection card companies profiled in this report include-

• QIAGEN

• PerkinElmer

• DBS System

• Danaher

• Eastern Business Forms

• Ahlstrom

• ARCHIMED Life Science

• GenTegra

• FortiusBio

• CENTOGENE

Specimen Collection Card by Segment

The study includes a forecast for the global specimen collection card by type, product type, application, end use, and region.

Specimen Collection Card Market by Type [Analysis by Value from 2018 to 2030]:

• Blood

• Saliva

• Urine

• Buccal Cells

• Others

Specimen Collection Card Market by Product Type [Analysis by Value from 2018 to 2030]:

• Whatman 903

• Ahlstrom 226

• FTA

• Others

Specimen Collection Card Market by Application [Analysis by Value from 2018 to 2030]:

• New Born Screening

• Infectious Diseases Testing

• Therapeutic Drug Monitoring

• Forensics

• Research

• Wellbeing/Health Monitoring

Specimen Collection Card Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics

• Diagnostics Centers

• Others

Specimen Collection Card Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America

• Europe

• Asia Pacific

• The Rest of the World

Country Wise Outlook for the Specimen Collection Card Market

The global specimen collection cards market is growing rapidly due to increasing demand for healthcare, the development of diagnostic technology, and increased emphasis on early disease detection. Specimen collection cards are key in gathering and transporting biological samples and are applicable in various diagnoses, such as genetic testing, newborn screening, and infectious diseases. Understanding the country-wise view of the specimen collection card market provides important information regarding regional growth trends, market dynamics, and opportunities. Different countries have varying demands and market potentials, depending on their healthcare infrastructure, regulatory environments, and public health priorities.

• United States: Newborn screening and infectious disease testing are two major areas where recent breakthroughs in specimen collection cards have concentrated on improving their accuracy in medicine. For instance, there is integration of high-performance biological marker detection techniques and improvements in card design to reduce risk from environmental contaminants. Additionally, digital integration has improved healthcare outcomes through streamlined data capture and analysis.

• China: Affordability and scalability are key trends driving the Chinese market for specimen collection cards. Recent developments involve rolling out affordable sample collection kits suitable for mass screening programs while enhancing the production process to comply with local regulations, including those set by international standards organizations like ISO9001/13485. This has helped improve quality control measures over time, reflecting China's growing capacity in this field.

• Germany: Innovations in materials science are shaping advances in the specimen collection card field across Germany today. These have seen enhancements in materials used for improved biocompatibility and integration with electronic health record systems. In strict compliance with European regulations and quality standards, German companies have embarked on research aimed at improving sensitivity and accuracy in tests involving these entities.

• India: To achieve greater accessibility and affordability, India’s specimen collection card market is undergoing transformations. Recent developments include cards designed for various diagnostic applications, such as newborn screening and infectious disease testing. Efforts are also being made to improve distribution networks and support systems targeted at rural healthcare settings.

• Japan: Japan is leading in incorporating the latest technology into specimen collection cards, such as digital health platforms. Recent innovations include highly functional materials that enhance sample stability and accuracy during analysis. There is also an emphasis on real-time monitoring and data analysis through the integration of specimen collection cards with digital healthcare platforms.

Features of the Global Specimen Collection Card Market

Market Size Estimates: Specimen collection card market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Specimen collection card market size by various segments, such as by type, product type, application, end use, and region in terms of value ($B). Regional Analysis: Specimen collection card market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different type, product type, application, end use, and regions for the specimen collection card market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the specimen collection card market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the growth forecast for specimen collection card market? Answer: The global specimen collection card market is expected to grow with a CAGR of 5.3% from 2024 to 2030. Q2. What are the major drivers influencing the growth of the specimen collection card market? Answer: The major drivers for this market are rising emphasis on non-invasive procedures and growing cases of infectious diseases. Q3. What are the major segments for specimen collection card market? Answer: The future of the specimen collection card market looks promising with opportunities in the hospital & clinic and diagnostic center markets. Q4. Who are the key specimen collection card market companies? Answer: Some of the key specimen collection card companies are as follows:

• QIAGEN

• PerkinElmer

• DBS System

• Danaher

• Eastern Business Forms

• Ahlstrom

• ARCHIMED Life Science

• GenTegra

• FortiusBio

• CENTOGENE Q5. Which specimen collection card market segment will be the largest in future? Answer: Lucintel forecasts that new born screening will remain the largest segment over the forecast period. Q6. In specimen collection card market, which region is expected to be the largest in next 5 years? Answer: North America will remain the largest region over the forecast period. Q7. Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.